Tower Research Capital (TRC)’s Dyne Therapeutics DYN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $99.9K | Buy |
10,495
+7,697
| +275% | +$73.3K | ﹤0.01% | 2377 |
|
|
2025
Q1 | $29.3K | Sell |
2,798
-13,220
| -83% | -$138K | ﹤0.01% | 2635 |
|
|
2024
Q4 | $377K | Buy |
16,018
+14,396
| +888% | +$339K | 0.01% | 1258 |
|
|
2024
Q3 | $58.3K | Sell |
1,622
-12,432
| -88% | -$447K | ﹤0.01% | 2639 |
|
|
2024
Q2 | $496K | Buy |
14,054
+13,477
| +2,336% | +$476K | 0.01% | 1351 |
|
|
2024
Q1 | $16.4K | Sell |
577
-6,218
| -92% | -$177K | ﹤0.01% | 3187 |
|
|
2023
Q4 | $90.4K | Sell |
6,795
-1,194
| -15% | -$15.9K | ﹤0.01% | 2725 |
|
|
2023
Q3 | $71.6K | Sell |
7,989
-414
| -5% | -$3.71K | ﹤0.01% | 2247 |
|
|
2023
Q2 | $94.5K | Buy |
8,403
+7,130
| +560% | +$80.2K | ﹤0.01% | 2045 |
|
|
2023
Q1 | $15K | Buy |
1,273
+538
| +73% | +$6.34K | ﹤0.01% | 3779 |
|
|
2022
Q4 | $9K | Sell |
735
-8,847
| -92% | -$108K | ﹤0.01% | 4189 |
|
|
2022
Q3 | $122K | Buy |
9,582
+7,757
| +425% | +$98.8K | ﹤0.01% | 2389 |
|
|
2022
Q2 | $13K | Sell |
1,825
-24,819
| -93% | -$177K | ﹤0.01% | 4202 |
|
|
2022
Q1 | $257K | Buy |
26,644
+25,596
| +2,442% | +$247K | ﹤0.01% | 1561 |
|
|
2021
Q4 | $12K | Sell |
1,048
-410
| -28% | -$4.7K | ﹤0.01% | 4266 |
|
|
2021
Q3 | $23K | Sell |
1,458
-307
| -17% | -$4.84K | ﹤0.01% | 3590 |
|
|
2021
Q2 | $37K | Buy |
1,765
+963
| +120% | +$20.2K | ﹤0.01% | 3277 |
|
|
2021
Q1 | $12K | Buy |
802
+353
| +79% | +$5.28K | ﹤0.01% | 4252 |
|
|
2020
Q4 | $9K | Buy |
449
+326
| +265% | +$6.54K | ﹤0.01% | 4376 |
|
|
2020
Q3 | $2K | Buy |
+123
| New | +$2K | ﹤0.01% | 4578 |
|